Tatsis Ourania sold VRTX
December 3, 2025 · Form 4 insider transaction
Tatsis Ourania sold 4,500 shares of Vertex Pharmaceuticals Incorporated at $449.99 per share, a transaction worth $2.02M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.; Open market sales reported on this line occurred at a weighted average price of $449.99 (range $449.99 to $450.00).; Dr. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.